サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1624346

オリゴヌクレオチド市場：世界の産業分析、規模、シェア、成長、動向、予測、2024年～2034年

Oligonucleotides Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

出版日
ページ情報
英文 172 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
オリゴヌクレオチド市場：世界の産業分析、規模、シェア、成長、動向、予測、2024年～2034年
出版日: 2024年11月25日
発行: Transparency Market Research
ページ情報: 英文 172 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

オリゴヌクレオチド市場 - 調査範囲

世界のオリゴヌクレオチド市場に関するTMRの調査レポートは、2024年から2034年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。本レポートでは、2024年を基準年、2034年を予測年として、2018年から2034年までの世界のオリゴヌクレオチド市場の収益と予測を提供します。また、2024年から2034年までの世界のオリゴヌクレオチド市場の複合年間成長率（CAGR %）も掲載しています。

本レポートは広範な調査を経て作成されています。1次調査では、アナリストが主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。2次調査では、主要企業の製品資料、アニュアルレポート、プレスリリース、関連資料などを参照し、オリゴヌクレオチド市場を推察しました。

市場スナップショット
2023年の市場金額 37億米ドル
2034年の市場金額 131億米ドル
CAGR 11.9%

当レポートでは、世界のオリゴヌクレオチド市場の競合情勢について調査しています。世界のオリゴヌクレオチド市場で事業を展開する主要企業が特定され、各企業が様々な属性でプロファイルされています。企業概要、財務状況、最近の動向、SWOTが本レポートで紹介されている世界のオリゴヌクレオチド市場におけるプレイヤーの属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界の市場分析と予測、2020年～2034年

第5章 主要洞察

  • 世界で開発されている数：主要地域別
  • 人気商品一覧
  • 価格分析
  • 市場参入戦略
  • エンドユーザーにとっての重要な購入指標
  • PESTEL分析
  • 主要な業界イベント
  • ポーターのファイブフォース分析
  • 主要国・地域別の規制シナリオ
  • 製品 / ブランド分析
  • ディストリビューターの情勢
  • 技術的進歩
  • 資金調達 / 投資シナリオ
  • 市場に関する提言とアナリストの見解

第6章 世界の市場分析と予測：タイプ別

  • イントロダクションと定義
  • 主な調査結果 / 発展
  • 市場金額予測：タイプ別、2020年～2034年
    • アンチセンス
    • DNA
    • siRNA
    • その他（CpG）
  • 市場の魅力：タイプ別

第7章 世界の市場分析と予測：用途別

  • イントロダクションと定義
  • 主な調査結果 / 発展
  • 市場金額予測：用途別、2020年～2034年
    • 分子生物学
    • 遺伝子治療
    • 医薬品開発
    • 診断
    • その他（ナノテクノロジー、調査調査等）
  • 市場の魅力：用途別

第8章 世界の市場分析と予測：エンドユーザー別

  • イントロダクションと定義
  • 主な調査結果 / 発展
  • 市場金額予測：エンドユーザー別、2020年～2034年
    • 病院
    • 製薬・バイオ医薬品企業
    • 診断検査室
    • バイオテクノロジー企業
    • CROとCMO
    • その他（学術調査機関等）
  • 市場の魅力：エンドユーザー別

第9章 世界の市場分析と予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 国・地域別の市場の魅力

第10章 北米の市場分析と予測

  • 米国
  • カナダ

第11章 欧州の市場分析と予測

  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州地域

第12章 アジア太平洋の市場分析と予測

  • 中国
  • インド
  • 日本
  • オーストラリア・ニュージーランド
  • その他アジア太平洋

第13章 ラテンアメリカの市場分析と予測

  • ブラジル
  • メキシコ
  • その他のラテンアメリカ

第14章 中東・アフリカの市場分析と予測

  • 南アフリカ
  • GCC諸国
  • その他中東・アフリカ地域

第15章 競合情勢

  • 市場企業 - 競合マトリックス（企業階層と規模別）
  • 市場シェア分析：企業別（2023年）
  • 企業プロファイル
    • Agilent Technologies
    • Ajinomoto Bio-Pharma Services
    • CordenPharma
    • Creative Biolabs
    • Ella Biotech
    • Eurofins Genomics
    • Future synthesis
    • Integrated DNA Technologies
    • Kaneka Eurogentec
    • Thermo Fisher Scientific Inc.
    • Merck
    • Microsynth
    • Nitto Avecia
図表

List of Tables

  • Table 01: Global Oligonucleotides Market Value (US$ Bn) Forecast, By Type, 2020-2034
  • Table 02: Global Oligonucleotides Market Value (US$ Bn) Forecast, By Application, 2020-2034
  • Table 03: Global Oligonucleotides Market Value (US$ Bn) Forecast, By End-user, 2020-2034
  • Table 04: Global Oligonucleotides Market Value (US$ Bn) Forecast, by Region, 2020-2034
  • Table 05: North America Oligonucleotides Market Value (US$ Bn) Forecast, by Country, 2020-2034
  • Table 06: North America Oligonucleotides Market Value (US$ Bn) Forecast, by Type, 2020-2034
  • Table 07: North America Oligonucleotides Market Value (US$ Bn) Forecast, by Application, 2020-2034
  • Table 08: North America Oligonucleotides Market Value (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 09: Europe Oligonucleotides Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 10: Europe Oligonucleotides Market Value (US$ Bn) Forecast, by Type, 2020-2034
  • Table 11: Europe Oligonucleotides Market Value (US$ Bn) Forecast, by Application, 2020-2034
  • Table 12: Europe Oligonucleotides Market Value (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 13: Asia Pacific Oligonucleotides Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 14: Asia Pacific Oligonucleotides Market Value (US$ Bn) Forecast, by Type, 2020-2034
  • Table 15: Asia Pacific Oligonucleotides Market Value (US$ Bn) Forecast, by Application, 2020-2034
  • Table 16: Asia Pacific Oligonucleotides Market Value (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 17: Latin America Oligonucleotides Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 18: Latin America Oligonucleotides Market Value (US$ Bn) Forecast, by Type, 2020-2034
  • Table 19: Latin America Oligonucleotides Market Value (US$ Bn) Forecast, by Application, 2020-2034
  • Table 20: Latin America Oligonucleotides Market Value (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 21: Middle East & Africa Oligonucleotides Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 22: Middle East & Africa Oligonucleotides Market Value (US$ Bn) Forecast, by Type, 2020-2034
  • Table 23: Middle East & Africa Oligonucleotides Market Value (US$ Bn) Forecast, by Application, 2020-2034
  • Table 24: Middle East & Africa Oligonucleotides Market Value (US$ Bn) Forecast, by End-user, 2020-2034

List of Figures

  • Figure 01: Global Oligonucleotides Market Value (US$ Bn) Forecast, 2020-2034
  • Figure 02: Global Oligonucleotides Market Value Share, by Type, 2023
  • Figure 03: Global Oligonucleotides Market Value Share, by Application, 2023
  • Figure 04: Global Oligonucleotides Market Value Share, by En d-user, 2023
  • Figure 05: Global Oligonucleotides Market Value Share, By Region, 2023
  • Figure 06: Global Oligonucleotides Market Value (US$ Bn) Share Analysis, By Type, 2023 and 2034
  • Figure 07: Global Oligonucleotides Market Share Analysis, By Type, 2023
  • Figure 08: Global Oligonucleotides Market Share Analysis, By Type, 2034
  • Figure 09: Global Oligonucleotides Market Attractiveness Analysis, By Type, 2024-2034
  • Figure 10: Global Oligonucleotides Market Value (US$ Bn), by Antisense Oligonucleotidess, 2020-2034
  • Figure 11: Global Oligonucleotides Market Value Share Analysis, by Antisense Oligonucleotidess, 2023 and 2034
  • Figure 12: Global Oligonucleotides Market Value (US$ Bn), by DNA, 2020-2034
  • Figure 13: Global Oligonucleotides Market Value Share Analysis, by DNA, 2023 and 2034
  • Figure 14: Global Oligonucleotides Market Value (US$ Bn), by siRNA, 2020-2034
  • Figure 15: Global Oligonucleotides Market Value Share Analysis, by siRNA, 2023 and 2034
  • Figure 16: Global Oligonucleotides Market Value (US$ Bn), by Others (CpG Oligonucleotidess) , 2020-2034
  • Figure 17: Global Oligonucleotides Market Value Share Analysis, by Others (CpG Oligonucleotidess), 2023 and 2034
  • Figure 18: Global Oligonucleotides Market Value (US$ Bn) Share Analysis, By Application, 2023 and 2034
  • Figure 19: Global Oligonucleotides Market Share Analysis, By Application, 2023
  • Figure 20: Global Oligonucleotides Market Share Analysis, By Application, 2034
  • Figure 21: Global Oligonucleotides Market Attractiveness Analysis, By Application, 2024-2034
  • Figure 22: Global Oligonucleotides Market Value (US$ Bn), by Molecular Biology, 2020-2034
  • Figure 23: Global Oligonucleotides Market Value Share Analysis, by Molecular Biology, 2023 and 2034
  • Figure 24: Global Oligonucleotides Market Value (US$ Bn), by Gene Therapy, 2020-2034
  • Figure 25: Global Oligonucleotides Market Value Share Analysis, by Genetic Disorders, 2023 and 2034
  • Figure 26: Global Oligonucleotides Market Value (US$ Bn), by Drug Development, 2020-2034
  • Figure 27: Global Oligonucleotides Market Value Share Analysis, by Drug Development, 2023 and 2034
  • Figure 27: Global Oligonucleotides Market Value (US$ Bn), by Rare Diseases, 2020-2034
  • Figure 29: Global Oligonucleotides Market Value Share Analysis, by Diagnostics, 2023 and 2034
  • Figure 30: Global Oligonucleotides Market Value (US$ Bn), by Others, 2020-2034
  • Figure 31: Global Oligonucleotides Market Value Share Analysis, by Others, 2023 and 2034
  • Figure 32: Global Oligonucleotides Market Value (US$ Bn) Share Analysis, By End-user, 2023 and 2034
  • Figure 33: Global Oligonucleotides Market Share Analysis, By End-user, 2023
  • Figure 34: Global Oligonucleotides Market Share Analysis, By End-user, 2034
  • Figure 35: Global Oligonucleotides Market Attractiveness Analysis, By End-user, 2024-2034
  • Figure 36: Global Oligonucleotides Market Value (US$ Bn), by Hospitals, 2020-2034
  • Figure 37: Global Oligonucleotides Market Value Share Analysis, by Hospitals, 2023 and 2034
  • Figure 38: Global Oligonucleotides Market Value (US$ Bn), by Pharma & Biopharma Companies, 2020-2034
  • Figure 39: Global Oligonucleotides Market Value Share Analysis, by Pharma & Biopharma Companies, 2023 and 2034
  • Figure 40: Global Oligonucleotides Market Value (US$ Bn), by Diagnostic Laboratories, 2020-2034
  • Figure 41: Global Oligonucleotides Market Value Share Analysis, by Diagnostic Laboratories, 2023 and 2034
  • Figure 42: Global Oligonucleotides Market Value (US$ Bn), by Biotechnology Companies, 2020-2034
  • Figure 43: Global Oligonucleotides Market Value Share Analysis, by Biotechnology Companies, 2023 and 2034
  • Figure 44: Global Oligonucleotides Market Value (US$ Bn), by CROs and CMOs, 2020-2034
  • Figure 45: Global Oligonucleotides Market Value Share Analysis, by CROs and CMOs, 2023 and 2034
  • Figure 46: Global Oligonucleotides Market Value (US$ Bn), Others, 2020-2034
  • Figure 47: Global Oligonucleotides Market Value Share Analysis, by Others, 2023 and 2034
  • Figure 48: Global Oligonucleotides Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 49: Global Oligonucleotides Market Share Analysis, by Region, 2023
  • Figure 50: Global Oligonucleotides Market Share Analysis, by Region, 2034
  • Figure 51: Global Oligonucleotides Market Attractiveness Analysis, by Region, 2023-2034
  • Figure 52: North America Oligonucleotides Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 53: North America Oligonucleotides Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 54: North America Oligonucleotides Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 55: North America Oligonucleotides Market Value (US$ Bn) Share Analysis, by Type, 2023 and 2034
  • Figure 56: North America Oligonucleotides Market Attractiveness Analysis, by Type, 2024-2034
  • Figure 57: North America Oligonucleotides Market Value (US$ Bn) Share Analysis, by Application, 2023 and 2034
  • Figure 58: North America Oligonucleotides Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 59: North America Oligonucleotides Market Value (US$ Bn) Share Analysis, by End-user, 2023 and 2034
  • Figure 60: North America Oligonucleotides Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 61: Europe Oligonucleotides Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 62: Europe Oligonucleotides Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 63: Europe Oligonucleotides Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 64: Europe Oligonucleotides Market Value (US$ Bn) Share Analysis, by Type, 2023 and 2034
  • Figure 65: Europe Oligonucleotides Market Attractiveness Analysis, by Type, 2024-2034
  • Figure 66: Europe Oligonucleotides Market Value (US$ Bn) Share Analysis, by Application, 2023 and 2034
  • Figure 67: Europe Oligonucleotides Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 68: Europe Oligonucleotides Market Value (US$ Bn) Share Analysis, by End-user, 2023 and 2034
  • Figure 69: Europe Oligonucleotides Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 70: Asia Pacific Oligonucleotides Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 71: Asia Pacific Oligonucleotides Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 72: Asia Pacific Oligonucleotides Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 73: Asia Pacific Oligonucleotides Market Value (US$ Bn) Share Analysis, by Type, 2023 and 2034
  • Figure 74: Asia Pacific Oligonucleotides Market Attractiveness Analysis, by Type, 2024-2034
  • Figure 75: Asia Pacific Oligonucleotides Market Value (US$ Bn) Share Analysis, by Application, 2023 and 2034
  • Figure 76: Asia Pacific Oligonucleotides Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 77: Asia Pacific Oligonucleotides Market Value (US$ Bn) Share Analysis, by End-user, 2023 and 2034
  • Figure 78: Asia Pacific Oligonucleotides Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 79: Latin America Oligonucleotides Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 80: Latin America Oligonucleotides Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 81: Latin America Oligonucleotides Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 82: Latin America Oligonucleotides Market Value (US$ Bn) Share Analysis, by Type, 2023 and 2034
  • Figure 83: Latin America Oligonucleotides Market Attractiveness Analysis, by Type, 2024-2034
  • Figure 84: Latin America Oligonucleotides Market Value (US$ Bn) Share Analysis, by Application, 2023 and 2034
  • Figure 85: Latin America Oligonucleotides Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 86: Latin America Oligonucleotides Market Value (US$ Bn) Share Analysis, by End-user, 2023 and 2034
  • Figure 87: Latin America Oligonucleotides Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 88: Middle East & Africa Oligonucleotides Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 89: Middle East & Africa Oligonucleotides Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 90: Middle East & Africa Oligonucleotides Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 91: Middle East & Africa Oligonucleotides Market Value (US$ Bn) Share Analysis, by Type, 2023 and 2034
  • Figure 92: Middle East & Africa Oligonucleotides Market Attractiveness Analysis, by Type, 2024-2034
  • Figure 93: Middle East & Africa Oligonucleotides Market Value (US$ Bn) Share Analysis, by Application, 2023 and 2034
  • Figure 94: Middle East & Africa Oligonucleotides Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 95: Middle East & Africa Oligonucleotides Market Value (US$ Bn) Share Analysis, by End-user, 2023 and 2034
  • Figure 96: Middle East & Africa Oligonucleotides Market Attractiveness Analysis, by End-user, 2024-2034
目次
Product Code: TMRGL86409

Oligonucleotides Market - Scope of Report

TMR's report on the global oligonucleotides market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global oligonucleotides market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global oligonucleotides market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the oligonucleotides market.

Market Snapshot
Market Value in 2023US$ 3.7 Bn
Market Value in 2034US$ 13.1 Bn
CAGR11.9%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global oligonucleotides market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global oligonucleotides market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global oligonucleotides market.

The report delves into the competitive landscape of the global oligonucleotides market. Key players operating in the global oligonucleotides market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global oligonucleotides market profiled in this report.

Key Questions Answered in Global oligonucleotides Market Report:

  • What is the sales/revenue generated by oligonucleotides across all regions during the forecast period?
  • What are the opportunities in the global oligonucleotides market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Oligonucleotides Market - Research Objectives and Research Approach

The comprehensive report on the global oligonucleotides market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global oligonucleotides market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global oligonucleotides market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Oligonucleotides Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segmentation Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Oligonucleotides Market Analysis and Forecasts, 2020-2034
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. No. of Oligonucleotides being developed in world by Key Regions
  • 5.2. List of top Oligonucleotides products
  • 5.3. Pricing Analysis
  • 5.4. Go-to-Market Strategy
  • 5.5. Key Purchase Metrics for End-users
  • 5.6. PESTEL Analysis
  • 5.7. Key Industry Events
  • 5.8. Porter's Five Forces Analysis
  • 5.9. Regulatory Scenario by Key Countries/Regions
  • 5.10. Product/Brand Analysis
  • 5.11. Distributors Landscape
  • 5.12. Technological Advancements
  • 5.13. Fund Raise/Investment Scenario
  • 5.14. Recommendations and Analyst View for the Market

6. Global Oligonucleotides Market Analysis and Forecasts, By Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Type, 2020-2034
    • 6.3.1. Antisense Oligonucleotides
    • 6.3.2. DNA
    • 6.3.3. siRNA
    • 6.3.4. Others (CpG Oligonucleotides)
  • 6.4. Market Attractiveness By Type

7. Global Oligonucleotides Market Analysis and Forecasts, By Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Application, 2020-2034
    • 7.3.1. Molecular Biology
    • 7.3.2. Gene Therapy
    • 7.3.3. Drug Development
    • 7.3.4. Diagnostics
    • 7.3.5. Others (Nanotechnology, Research studies etc.)
  • 7.4. Market Attractiveness By Application

8. Global Oligonucleotides Market Analysis and Forecasts, By End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By End-user, 2020-2034
    • 8.3.1. Hospitals
    • 8.3.2. Pharma & Biopharma Companies
    • 8.3.3. Diagnostic Laboratories
    • 8.3.4. Biotechnology Companies
    • 8.3.5. CROs and CMOs
    • 8.3.6. Others (Academic Research Institutes, etc.)
  • 8.4. Market Attractiveness By End-user

9. Global Oligonucleotides Market Analysis and Forecasts, By Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast By Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness By Country/Region

10. North America Oligonucleotides Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast By Type, 2020-2034
    • 10.2.1. Antisense Oligonucleotides
    • 10.2.2. DNA
    • 10.2.3. siRNA
    • 10.2.4. Others (CpG Oligonucleotides)
  • 10.3. Market Value Forecast By Application, 2020-2034
    • 10.3.1. Molecular Biology
    • 10.3.2. Gene Therapy
    • 10.3.3. Drug Development
    • 10.3.4. Diagnostics
    • 10.3.5. Others (Nanotechnology, Research studies etc.)
  • 10.4. Market Value Forecast By End-user, 2020-2034
    • 10.4.1. Hospitals
    • 10.4.2. Pharma & Biopharma Companies
    • 10.4.3. Diagnostic Laboratories
    • 10.4.4. Biotechnology Companies
    • 10.4.5. CROs and CMOs
    • 10.4.6. Others (Academic Research Institutes, etc.)
  • 10.5. Market Value Forecast By Country, 2020-2034
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Type
    • 10.6.2. By Application
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Oligonucleotides Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Type, 2020-2034
    • 11.2.1. Antisense Oligonucleotides
    • 11.2.2. DNA
    • 11.2.3. siRNA
    • 11.2.4. Others (CpG Oligonucleotides)
  • 11.3. Market Value Forecast By Application, 2020-2034
    • 11.3.1. Molecular Biology
    • 11.3.2. Gene Therapy
    • 11.3.3. Drug Development
    • 11.3.4. Diagnostics
    • 11.3.5. Others (Nanotechnology, Research studies etc.)
  • 11.4. Market Value Forecast By End-user, 2020-2034
    • 11.4.1. Hospitals
    • 11.4.2. Pharma & Biopharma Companies
    • 11.4.3. Diagnostic Laboratories
    • 11.4.4. Biotechnology Companies
    • 11.4.5. CROs and CMOs
    • 11.4.6. Others (Academic Research Institutes, etc.)
  • 11.5. Market Value Forecast By Country/Sub-region, 2020-2034
    • 11.5.1. Germany
    • 11.5.2. UK
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Type
    • 11.6.2. By Application
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Oligonucleotides Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Type, 2020-2034
    • 12.2.1. Antisense Oligonucleotides
    • 12.2.2. DNA
    • 12.2.3. siRNA
    • 12.2.4. Others (CpG Oligonucleotides)
  • 12.3. Market Value Forecast By Application, 2020-2034
    • 12.3.1. Molecular Biology
    • 12.3.2. Gene Therapy
    • 12.3.3. Drug Development
    • 12.3.4. Diagnostics
    • 12.3.5. Others (Nanotechnology, Research studies etc.)
  • 12.4. Market Value Forecast By End-user, 2020-2034
    • 12.4.1. Hospitals
    • 12.4.2. Pharma & Biopharma Companies
    • 12.4.3. Diagnostic Laboratories
    • 12.4.4. Biotechnology Companies
    • 12.4.5. CROs and CMOs
    • 12.4.6. Others (Academic Research Institutes, etc.)
  • 12.5. Market Value Forecast By Country/Sub-region, 2020-2034
    • 12.5.1. China
    • 12.5.2. India
    • 12.5.3. Japan
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Type
    • 12.6.2. By Application
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America Oligonucleotides Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Type, 2020-2034
    • 13.2.1. Antisense Oligonucleotides
    • 13.2.2. DNA
    • 13.2.3. siRNA
    • 13.2.4. Others (CpG Oligonucleotides)
  • 13.3. Market Value Forecast By Application, 2020-2034
    • 13.3.1. Molecular Biology
    • 13.3.2. Gene Therapy
    • 13.3.3. Drug Development
    • 13.3.4. Diagnostics
    • 13.3.5. Others (Nanotechnology, Research studies etc.)
  • 13.4. Market Value Forecast By End-user, 2020-2034
    • 13.4.1. Hospitals
    • 13.4.2. Pharma & Biopharma Companies
    • 13.4.3. Diagnostic Laboratories
    • 13.4.4. Biotechnology Companies
    • 13.4.5. CROs and CMOs
    • 13.4.6. Others (Academic Research Institutes, etc.)
  • 13.5. Market Value Forecast By Country/Sub-region, 2020-2034
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of LATAM
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Type
    • 13.6.2. By Application
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Oligonucleotides Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Type, 2020-2034
    • 14.2.1. Antisense Oligonucleotides
    • 14.2.2. DNA
    • 14.2.3. siRNA
    • 14.2.4. Others (CpG Oligonucleotides)
  • 14.3. Market Value Forecast By Application, 2020-2034
    • 14.3.1. Molecular Biology
    • 14.3.2. Gene Therapy
    • 14.3.3. Drug Development
    • 14.3.4. Diagnostics
    • 14.3.5. Others (Nanotechnology, Research studies etc.)
  • 14.4. Market Value Forecast By End-user, 2020-2034
    • 14.4.1. Hospitals
    • 14.4.2. Pharma & Biopharma Companies
    • 14.4.3. Diagnostic Laboratories
    • 14.4.4. Biotechnology Companies
    • 14.4.5. CROs and CMOs
    • 14.4.6. Others (Academic Research Institutes, etc.)
  • 14.5. Market Value Forecast By Country/Sub-region, 2020-2034
    • 14.5.1. South Africa
    • 14.5.2. GCC Countries
    • 14.5.3. Rest of MEA
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Type
    • 14.6.2. By Application
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Market Share Analysis By Company (2023)
  • 15.3. Company Profiles
    • 15.3.1. Agilent Technologies
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. Financial Overview
      • 15.3.1.4. SWOT Analysis
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Ajinomoto Bio-Pharma Services
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. Financial Overview
      • 15.3.2.4. SWOT Analysis
      • 15.3.2.5. Strategic Overview
    • 15.3.3. CordenPharma
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. Financial Overview
      • 15.3.3.4. SWOT Analysis
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Creative Biolabs
      • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. Financial Overview
      • 15.3.4.4. SWOT Analysis
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Ella Biotech
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. Financial Overview
      • 15.3.5.4. SWOT Analysis
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Eurofins Genomics
      • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. Financial Overview
      • 15.3.6.4. SWOT Analysis
      • 15.3.6.5. Strategic Overview
    • 15.3.7. Future synthesis
      • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. Financial Overview
      • 15.3.7.4. SWOT Analysis
      • 15.3.7.5. Strategic Overview
    • 15.3.8. Integrated DNA Technologies
      • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. Financial Overview
      • 15.3.8.4. SWOT Analysis
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Kaneka Eurogentec
      • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. Financial Overview
      • 15.3.9.4. SWOT Analysis
      • 15.3.9.5. Strategic Overview
    • 15.3.10. Thermo Fisher Scientific Inc.
      • 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.10.2. Product Portfolio
      • 15.3.10.3. Financial Overview
      • 15.3.10.4. SWOT Analysis
      • 15.3.10.5. Strategic Overview
    • 15.3.11. Merck
      • 15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.11.2. Product Portfolio
      • 15.3.11.3. Financial Overview
      • 15.3.11.4. SWOT Analysis
      • 15.3.11.5. Strategic Overview
    • 15.3.12. Microsynth
      • 15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.12.2. Product Portfolio
      • 15.3.12.3. Financial Overview
      • 15.3.12.4. SWOT Analysis
      • 15.3.12.5. Strategic Overview
    • 15.3.13. Nitto Avecia
      • 15.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.13.2. Product Portfolio
      • 15.3.13.3. Financial Overview
      • 15.3.13.4. SWOT Analysis
      • 15.3.13.5. Strategic Overview